Nuveen New York Select Tax-Free Income Portfolio (NYSE:NXN – Get Free Report) saw a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 11,100 shares, a decline of 25.0% from the November 15th total of 14,800 shares. Based on an average daily trading volume, of 9,000 shares, the days-to-cover ratio is currently 1.2 days.
Nuveen New York Select Tax-Free Income Portfolio Price Performance
NXN traded down $0.07 during trading on Friday, hitting $11.69. 12,726 shares of the company traded hands, compared to its average volume of 8,741. Nuveen New York Select Tax-Free Income Portfolio has a one year low of $11.04 and a one year high of $12.40. The stock’s fifty day moving average is $11.95 and its 200 day moving average is $11.86.
Nuveen New York Select Tax-Free Income Portfolio Dividend Announcement
The business also recently announced a monthly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Friday, December 13th will be given a dividend of $0.042 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 4.31%. The ex-dividend date of this dividend is Friday, December 13th.
Institutional Investors Weigh In On Nuveen New York Select Tax-Free Income Portfolio
About Nuveen New York Select Tax-Free Income Portfolio
Nuveen New York Select Tax-Free Income Portfolio is a closed-ended fixed income mutual fund launched by Nuveen Investments Inc The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in the fixed income markets of New York. The fund invests in the securities of companies that operate across diversified sectors.
Read More
- Five stocks we like better than Nuveen New York Select Tax-Free Income Portfolio
- Find and Profitably Trade Stocks at 52-Week Lows
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to buy stock: A step-by-step guide for beginners
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Top Stocks Investing in 5G Technology
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Nuveen New York Select Tax-Free Income Portfolio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuveen New York Select Tax-Free Income Portfolio and related companies with MarketBeat.com's FREE daily email newsletter.